Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Trial of Ampakine Added to Clozapine, Olanzapine or Risperidone in Patients With Schizophrenia (CX516)

This study has been completed.
Sponsor:
Collaborator:
Cortex Pharmaceuticals
Information provided by:
North Suffolk Mental Health Association
ClinicalTrials.gov Identifier:
NCT00235352
First received: October 6, 2005
Last updated: February 25, 2009
Last verified: February 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2007
  Primary Completion Date: April 2005 (Final data collection date for primary outcome measure)
Publications: